An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

Astellas

Status and phase: Completed; Phase 3

Conditions: Myasthenia Gravis

Treatments: Drug: tacrolimus

Study type: Interventional

Funder types: Industry

Identifiers

NCT00309101

F506-CL-0602

Details and patient eligibility

About

The purpose of the study is to investigate the efficacy and safety for steroid resistant, non-thymectomized MG patients.

Enrollment: 11 patients

Sex: All

Ages: 16 to 64 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinically diagnosed as myasthenia gravis
• Those whose MG symptoms are not controlled by the treatment with prednisone

Exclusion criteria

• Those who had undergone thymectomy

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

11 participants in 1 patient group

1. tacrolimus

Experimental group

Treatment:

Drug: tacrolimus